PEOPLE TAKING GLP-1S have a reduced risk of heart attacks, strokes, and death from cardiovascular disease, according to a ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger ...

Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose funding it ...

A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...

which may include a prescription for a weight loss medication. Available Ozempic alternatives: Zepbound, Saxenda, Wegovy, Mounjaro, and Metformin Keep in mind that location, eligibility criteria ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Discover the unexpected health benefits of diabetes and weight loss medications like Ozempic and Wegovy. Find out how these ...

GLP-1s currently used for weight loss—although not all are expressly approved for this purpose—include Ozempic and Wegovy (semaglutide), Victoza and Saxenda (liraglutide), and Mounjaro and ...